AI assistant
GILEAD SCIENCES, INC. — Director's Dealing 2015
May 5, 2015
29828_dirs_2015-05-05_ba6560d0-fde7-4ae5-bfe9-b92e28d6cb14.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2015-05-01
Reporting Person: Washington Robin L (EVP, CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-05-01 | Common Stock | M | 11250 | $24.295 | Acquired | 38974 | Direct |
| 2015-05-01 | Common Stock | M | 5592 | $40.56 | Acquired | 44566 | Direct |
| 2015-05-01 | Common Stock | S | 2200 | $103.4823 | Disposed | 42366 | Direct |
| 2015-05-01 | Common Stock | S | 3700 | $104.2278 | Disposed | 38666 | Direct |
| 2015-05-01 | Common Stock | S | 5742 | $105.3269 | Disposed | 32924 | Direct |
| 2015-05-01 | Common Stock | S | 5200 | $106.0219 | Disposed | 27724 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-05-01 | Non-Qualified Stock Option (right to buy) | $24.295 | M | 11250 | Disposed | 2022-01-26 | Common Stock (11250) | Direct |
| 2015-05-01 | Non-Qualified Stock Option (right to buy) | $40.56 | M | 5592 | Disposed | 2023-02-01 | Commmon Stock (5592) | Direct |
Footnotes
F1: The sale transactions reported in this Form 4 are made pursuant to a Rule 10b5-1 trading plan.
F2: The options have a four year vesting schedule. 25% of the options will vest on the first anniversary date of the grant. The balance will vest 6.25% quarterly thereafter until fully vested.
F3: Sale prices reported for the transactions reported here range from $102.81 to $103.80. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F4: Sale prices reported for the transactions reported here range from $103.81 to $104.80. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F5: Sale prices reported for the transactions reported here range from $104.81 to $105.80. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.
F6: Sale prices reported for the transactions reported here range from $105.82 to $106.27. Full information regarding the number of shares purchased or sold at each separate price will be provided to the SEC, the issuer or its shareowners upon request.